Page last updated: 2024-08-17

adenosine monophosphate and Myocardial Infarction

adenosine monophosphate has been researched along with Myocardial Infarction in 97 studies

Research

Studies (97)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (18.56)	18.7374
1990's	5 (5.15)	18.2507
2000's	13 (13.40)	29.6817
2010's	51 (52.58)	24.3611
2020's	10 (10.31)	2.80

Authors

Authors	Studies
Bhatt, DL; Cavender, MA; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Lopes, RD; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Lopes, RD; Mahaffey, KW; Peterson, BE; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Angiolillo, DJ; Bhatt, DL; Davidson-Ray, L; Dell'Anna, C; Diaz, M; Edwards, L; El-Sabae, H; Garratt, KN; Ohman, EM; Rymer, JA; Salahuddin, K; Tasissa, G; Waksman, R; Wang, TY; Washam, JB	1
Dobrzyn, P; Ellert-Miklaszewska, A; Gan, AM; Navrulin, VO; Ntambi, JM; Tracz-Gaszewska, Z	1
Amaradasa, KS; Chen, J; Edel, JB; Fu, J; Gorelik, J; Ivanov, AP; Kibreab, I; Kondrashov, A; Kwan, Z; Leung, MM; Li, A; Mansfield, CA; Mohagaonkar, S; Nikolaev, VO; Paulose Nadappuram, B; Rothery, S; Sanchez-Alonso, JL; Subramanian, H; Swiatlowska, P; Wojciak-Stothard, B; Wright, PT	1
Alcedo, KP; Battaglia, RA; Minor, M; Snider, NT	1
Ciolek, AM; Eisenberger, AB; Garan, AR; Jennings, DL; Ma, K	1
Leonardi, S; Marianeschi, SM; Morici, N; Pedrazzini, G; Sirico, D; Soriano, F; Vignati, G	1
Biondi-Zoccai, G; Carulli, E; Cirillo, P; D'Alessandro, P; Ercolano, V; Esposito, G; Favale, S; Forleo, C; Giordano, A; Larosa, C; Moscarelli, M; Nestola, PL; Palmiotto, AI; Pepe, M	1
Duan, L; Zhao, H	1
Abnousi, F; Bhatt, DL; Deliargyris, EN; Desai, M; Ding, VY; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Sundaram, V; White, HD; Yang, L; Yong, CM	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Vaduganathan, M; White, HD	1
Bhatt, DL; Deliargyris, EN; Eisen, A; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Alexopoulos, D; Lekakis, J; Pappas, C; Sfantou, D	1
Deppen, J; García, AJ; Levit, RD; Shin, EY; Strobel, F; Tirouvanziam, R; Wang, L; Xu, K; Zemskova, M	1
Banerjee, S; Baskar, A; Chauhan, S; Cui, Z; Dargham, BB; Sum-Ping, J; Tejani, I; Weideman, RA	1
Abtan, J; Bhatt, DL; Deliargyris, EN; Ducrocq, G; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Leonardi, S; Meani, P; Morici, N; Nava, S; Oliva, F; Oreglia, J; Ranucci, M; Rossini, R; Sacco, A; Viola, G	1
Armesilla, AL; Berry, C; Cotton, JM; Ford, TJ; Hothi, SS; Khan, N; Khogali, SS; Martins, J; McAlindon, EJ; Munir, S; Murray, HM; Thomas, MR; Townend, JN; Ubaid, S; Wrigley, B	1
Bhatt, DL; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Lopes, RD; Mahaffey, KW; Mangum, S; Olivier, CB; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD; Wilson, MD	1
Bhatt, DL; Gibson, CM; Harrington, RA; Leonardi, S; Mahaffey, KW; Neely, ML; Stone, GW; Tricoci, P; Truffa, AA; White, HD; Wilson, M	1
Mills, NL; Newby, DE; Shah, AS	1
Storey, RF	1
Mitka, M	1
Alhammouri, A; Cohen, MV; Cui, L; Downey, JM; Yang, XM	1
Bhatt, DL; Curzen, N; Gurbel, PA; Myat, A; Redwood, SR	1
Bhatt, DL; Day, JR; French, WJ; Gibson, CM; Gogia, HS; Gruberg, L; Hamm, CW; Harrington, RA; Iwaoka, RS; Leonardi, S; Liu, T; Mahaffey, KW; Skerjanec, S; Steg, PG; Stone, GW; Stuckey, TD; White, HD	1
Chatterjee, S; Mushiyev, S; Nairooz, R; Pekler, G; Sardar, P; Visco, F	1
Aryal Pandit, A; Aryal, MR; Hakim, FA; Jalota, L; Lee, HR; Mookadam, F; Pandit, A; Tleyjeh, IM	1
Limbruno, U; Musumeci, G	1
DiNicolantonio, JJ; Fortmann, SD; Pokov, AN; Serebruany, VL	1
Price, MJ; Walsh, JA	1
Fan, JY; Jin, C; Meng, J; Tang, XF; Yang, YJ; Yuan, JQ	1
Dobesh, PP; Oestreich, JH	1
Abbracchio, MP; Castiglioni, L; Colazzo, F; Cosentino, S; Nobili, E; Pesce, M; Rosa, P; Sironi, L; Tremoli, E	1
Aksentijević, D; Brookes, PS; Chouchani, ET; Costa, ASH; Dare, AJ; Davidson, SM; Duchen, MR; Eaton, S; Eyassu, F; Frezza, C; Gaude, E; Hartley, RC; Hu, CH; James, AM; Krieg, T; Logan, A; Murphy, MP; Nadtochiy, SM; Ord, ENJ; Pell, VR; Robb, EL; Robinson, AJ; Rogatti, S; Saeb-Parsy, K; Shattock, MJ; Shirley, R; Smith, AC; Sundier, SY; Work, LM	1
Alexeyev, M; Cohen, MV; Cui, L; Downey, JM; Gillespie, MN; Kuck, J; Ruchko, MV; White, J; Wilson, GL; Yang, XM	1
Bhatt, DL; Cortese, B; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Liu, T; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD; Wilensky, M	1
Bhatt, DL; Blankenship, JC; Deliargyris, EN; Généreux, P; Gibson, CM; Gutierrez, JA; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Liu, T; Mahaffey, KW; O'Donoghue, ML; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bell, RM; Cohen, MV; Downey, JM; White, J; Yang, XM; Yellon, DM	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Jatene, T; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bhatt, DL; Cavender, MA; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Abnousi, F; Bhatt, DL; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Lopes, RD; Mahaffey, KW; Mangum, S; Menozzi, A; Prats, J; Price, MJ; Steg, PG; Stone, GW; Todd, M; White, HD; Wilson, M	1
Abnousi, F; Abtan, J; Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bhatt, DL; Qamar, A	1
Andell, P; Erlinge, D; Götberg, M; James, S; Koul, S; Mohammad, MA; Scherstén, F	1
Bhatt, DL; Deliargyris, EN; Elkin, S; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Menozzi, A; Prats, J; Price, MJ; Steg, PG; Stone, GW; Vaduganathan, M; White, HD	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Sawlani, NN; Steg, PG; Stone, GW; White, HD	1
Lipinski, MJ; Torguson, R; Waksman, R; Westman, PC	1
Bagatini, MD; Battisti, V; dos Santos, RB; Gasparetto, D; Gonçalves, JF; Martins, CC; Morsch, VM; Rosa, CS; Schetinger, MR; Spanevello, RM	1
Moliterno, DJ	1
Amine, M; Angiolillo, DJ; Becker, RC; Bhatt, DL; Chew, DP; French, WJ; Gibson, CM; Goodman, SG; Harrington, RA; Kleiman, NS; Leisch, F; Lincoff, AM; Mahaffey, KW; McNulty, S; Montalescot, G; Parikh, KH; Pollack, CV; Skerjanec, S; Stone, GW; White, HD	1
Arneja, J; Bhatt, DL; Chew, DP; Cura, F; Gibson, CM; Goodman, SG; Harrington, RA; Jafar, MZ; Kleiman, NS; Lincoff, AM; Mahaffey, KW; Manoukian, SV; Manukov, I; McNulty, S; Montalescot, G; Pollack, CV; Skerjanec, S; Stone, GW; Tousek, F; White, HD; Widimsky, P	1
Ruparelia, N; Spyrou, N	1
Barrabés, JA; Figueras, J; Garcia-Dorado, D; Hernando, V; Inserte, J; Mirabet, M; Quiroga, A	1
Lee, KL	1
Bordel, V; Bruckner, B; Ghodsizad, A; Gregoric, I; Kallenbach, K; Karck, M; Kögler, G; Niehaus, M; Ruhparwar, A; Ungerer, MN	1
Bellemain, A; Collet, JP; Ecollan, P; Montalescot, G; Silvain, J	1
Bhatt, DL; Chew, DP; Dauerman, HL; Gibson, CM; Gruberg, L; Harrington, RA; Mahaffey, KW; Stone, GW; White, HD	1
Bhatt, DL; Dietrich, M; Gallup, D; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Liu, T; Mahaffey, KW; Price, MJ; Skerjanec, S; Steg, GW; Stone, GW; Todd, M; White, HD	1
Barn, K; Steinhubl, SR	1
Cohen, MV; Cui, L; Downey, JM; Kambayashi, J; Liu, Y; Tandon, N; Yang, X; Yang, XM	2
Roubille, F; Tardif, JC	1
Carneiro, M; Humphries, RG; Klein, A; Lincoff, AM; Murray, D; Penn, MS; Tarakji, K; Thomas, JD; Topol, EJ; Turner, J; Wang, K; Zhou, X; Zhou, Z	1
Dhalla, NS; Sethi, R	1
Bagchi, D; Bagchi, M; Juhasz, B; Maulik, N; Penumathsa, S; Shara, MA; Thatte, HS; Thirunavukkarasu, M; Yasmin, T; Zhan, L	1
Cattaneo, M	1
Rich, JD; Wiviott, SD	1
Borzak, S; Emanuelsson, H; Gibson, CM; Greenbaum, AB; Le May, MR; Lu, M; Ohman, EM; Stankowski, JE; Stebbins, AL; Weaver, WD	1
Eckle, T; Eltzschig, HK; Faigle, M; Grenz, A; Hart, ML; Köhler, D; Laucher, S; Mittelbronn, M; Müller, CE; Robson, SC	1
Hattori, S; Miyazaki, T; Mori, H; Nagata, M; Nakamura, Y; Ogawa, S; Sakurai, K; Takahashi, M	1
de la Morena García, E; González Isabel, C	1
Braunwald, E; DeBoer, LW; Ingwall, JS; Kloner, RA	1
Crome, R; Grannell, J; Hearse, DJ; Wyse, RK; Yellon, DM	1
Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Kurihara, T; Minamino, T; Node, K; Ueda, Y	1
Kapelko, VI; Kuzmin, AI; Lakomkin, VL; Vassort, G	1
Bünger, R; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Suzuki, K	1
Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K	1
Oldroyd, KG; Storey, RF; Wilcox, RG	1
Ellborg, M; Jacobsson, F; Swahn, E; Wallentin, L	1
Fetisova, TV; Sokolova, GG	1
Fetisova, TV; Khomaziuk, AI; Neshcheret, AP; Razumnaia, NM; Vorob'eva, TM	1
Fetisova, TV	1
Kolc, J; Kucerová, V; Málek, P	1
Geppert, E; Heugel, E; Isselhard, W; Lauterjung, KL; Menge, M; Vogel, W; Witte, J	1
Dai, DZ; Rong, P; Zhang, JE	1
Abd-Elfattah, AS; Brunsting, LA; Goldstein, JP; Murphy, CE; Salter, DR; Wechsler, AS	1
Hill, ML; Jennings, RB; Murry, CE; Reimer, KA; Yamasawa, I	1
Konttinen, A; Somer, H	1
Paterson, RA	1
Gomazkov, OA; Meerson, FZ	1
Razumnaia, NM	1
Kloppick, E; Krause, EG; Schneider, M; Vogel, I; Wollenberger, A	1
Opie, LH; Owen, P; Shulman, G; Thomas, M	1
Howell, BA; Kizer, DE	1

Reviews

17 review(s) available for adenosine monophosphate and Myocardial Infarction

Article	Year
Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73). American journal of physiology. Cell physiology, 2019, 12-01, Volume: 317, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Arteries; Calcinosis; Central Nervous System; Gene Expression Regulation; GPI-Linked Proteins; Heart Failure; Homeostasis; Humans; Mutation, Missense; Myocardial Infarction; Organ Specificity; Reperfusion Injury; Respiratory System	2019
Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives. Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:1 Topics: Adenosine Monophosphate; Clopidogrel; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine	2018
What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet (London, England), 2013, Aug-17, Volume: 382, Issue:9892 Topics: Adenosine Monophosphate; Administration, Oral; Anticoagulants; Combined Modality Therapy; Humans; Infusions, Parenteral; Integrin beta3; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Thrombolytic Therapy	2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet (London, England), 2013, Dec-14, Volume: 382, Issue:9909 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Cause of Death; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Treatment Outcome	2013
Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials. Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:1 Topics: Adenosine Monophosphate; Female; Hemorrhage; Humans; Male; Models, Biological; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; PubMed; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis	2014
Cangrelor versus clopidogrel in percutaneous coronary intervention: a systematic review and meta-analysis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Mar-20, Volume: 9, Issue:11 Topics: Adenosine Monophosphate; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticlopidine	2014
Cangrelor for treatment of arterial thrombosis. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4 Topics: Adenosine Monophosphate; Coronary Artery Disease; Coronary Thrombosis; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents	2014
Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. Atherosclerosis, 2014, Volume: 233, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Fibrinolytic Agents; Hemorrhage; Humans; Injections, Intravenous; Multicenter Studies as Topic; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Stents; Stroke; Sulfonamides; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine	2014
Optimizing the Use of Cangrelor in the Real World. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Animals; Clinical Trials as Topic; Coronary Artery Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis	2017
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis. Cardiovascular revascularization medicine : including molecular interventions, 2017, Volume: 18, Issue:2 Topics: Adenosine; Adenosine Monophosphate; Clopidogrel; Humans; Myocardial Infarction; Network Meta-Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome	2017
Advances in antiplatelet therapy for ACS and PCI. Journal of interventional cardiology, 2008, Volume: 21 Suppl 1 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angina, Unstable; Aspirin; Blood Platelets; Cardiac Catheterization; Fibrinolytic Agents; Humans; Lactones; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Treatment Outcome	2008
[Myocardial infarction: Role of new antiplatelet agents]. Presse medicale (Paris, France : 1983), 2011, Volume: 40, Issue:6 Topics: Adenosine; Adenosine Monophosphate; Administration, Oral; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Disease Management; Drug Resistance; Fibrinolytic Agents; Hemorrhage; Humans; Injections, Intravenous; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Reperfusion; Myocardial Revascularization; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticagrelor; Ticlopidine; Time Factors	2011
A brief review of the past and future of platelet P2Y12 antagonist. Coronary artery disease, 2012, Volume: 23, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clopidogrel; Coronary Artery Disease; Humans; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Stents; Sulfonamides; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2012
Platelet P2 receptors: old and new targets for antithrombotic drugs. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:1 Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Interactions; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Syndrome; Thiophenes; Ticagrelor; Ticlopidine	2007
New antiplatelet therapies for acute coronary syndromes. Current cardiology reports, 2007, Volume: 9, Issue:4 Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Blood Platelets; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Treatment Outcome	2007
Myocardial protection. Journal of cardiac surgery, 1986, Volume: 1, Issue:3 Topics: Adenosine Monophosphate; Animals; Antioxidants; Buffers; Calcium Channel Blockers; Cardiac Surgical Procedures; Cardioplegic Solutions; Citric Acid Cycle; Coronary Circulation; Diastole; Free Radicals; Heart; Heart Arrest, Induced; Heart Diseases; Heart Injuries; Humans; Hypothermia, Induced; Infant, Newborn; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Oxygen; Oxygen Consumption; Time Factors	1986
[Role of the sympathetic factor in the pathogenesis of myocardial infarct and isoproterenol necrosis]. Kardiologiia, 1971, Volume: 11, Issue:9 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Catecholamines; Cyclic AMP; Humans; Isoproterenol; Myocardial Infarction; Myocarditis; Myocardium; Oxygen Consumption; Stress, Psychological	1971

Trials

20 trial(s) available for adenosine monophosphate and Myocardial Infarction

Article	Year
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX. Circulation. Cardiovascular interventions, 2022, Volume: 15, Issue:1 Topics: Adenosine Monophosphate; Clopidogrel; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Treatment Outcome	2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION. Circulation. Cardiovascular interventions, 2022, Volume: 15, Issue:3 Topics: Adenosine Monophosphate; Hemorrhage; Humans; Myocardial Infarction; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Treatment Outcome	2022
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial. American heart journal, 2017, Volume: 188 Topics: Adenosine Monophosphate; Administration, Oral; Aged; Cause of Death; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Global Health; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Ticlopidine; Time Factors	2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX). The American journal of cardiology, 2017, Oct-01, Volume: 120, Issue:7 Topics: Adenosine Monophosphate; Aged; Anticoagulants; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome	2017
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials. International journal of cardiology, 2018, Jan-01, Volume: 250 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine; Treatment Outcome	2018
Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial. Thrombosis and haemostasis, 2019, Volume: 119, Issue:7 Topics: Adenosine Monophosphate; Aged; Blood Platelets; Blood Vessels; Cells, Cultured; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardium; Percutaneous Coronary Intervention; Platelet Activation; Platelet Function Tests; Receptors, Purinergic P2Y12; Regional Blood Flow; Ticagrelor	2019
Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3 Topics: Adenosine Monophosphate; Aged; Anticoagulants; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recombinant Proteins; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome	2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX. European heart journal, 2016, Apr-07, Volume: 37, Issue:14 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Femoral Artery; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Radial Artery; Stents; Ticlopidine; Treatment Outcome	2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial. Circulation, 2016, Jan-19, Volume: 133, Issue:3 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Disease Management; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sex Characteristics; Treatment Outcome	2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). Circulation, 2016, Sep-06, Volume: 134, Issue:10 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Disease Management; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine	2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. European heart journal. Acute cardiovascular care, 2018, Volume: 7, Issue:2 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; New Zealand; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; United States	2018
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. JACC. Cardiovascular interventions, 2016, 09-26, Volume: 9, Issue:18 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Angina, Stable; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials. JAMA cardiology, 2017, 02-01, Volume: 2, Issue:2 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Survival Rate; Treatment Outcome; United States	2017
Platelet inhibition with cangrelor in patients undergoing PCI. The New England journal of medicine, 2009, Dec-10, Volume: 361, Issue:24 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Double-Blind Method; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retreatment; Ticlopidine; Treatment Failure	2009
Intravenous platelet blockade with cangrelor during PCI. The New England journal of medicine, 2009, Dec-10, Volume: 361, Issue:24 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retreatment; Stents; Treatment Outcome	2009
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. American heart journal, 2012, Volume: 163, Issue:2 Topics: Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Treatment Outcome	2012
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial. American heart journal, 2012, Volume: 163, Issue:5 Topics: Adenosine Monophosphate; Adult; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Assessment; Survival Analysis; Ticlopidine; Treatment Outcome	2012
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angi American heart journal, 2007, Volume: 154, Issue:4 Topics: Adenosine Monophosphate; Coronary Angiography; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Humans; Infusions, Intravenous; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Tissue Plasminogen Activator; Vascular Patency	2007
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis and haemostasis, 2001, Volume: 85, Issue:3 Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Angina, Unstable; Aspirin; Blood Coagulation Tests; Consumer Product Safety; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12	2001
Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction. Clinical therapeutics, 2002, Volume: 24, Issue:5 Topics: Adenosine Monophosphate; Aged; Angina, Unstable; Double-Blind Method; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Infarction; Platelet Aggregation	2002

Other Studies

60 other study(ies) available for adenosine monophosphate and Myocardial Infarction

Article	Year
Cangrelor Use Patterns and Transition to Oral P2Y Journal of the American Heart Association, 2022, 06-07, Volume: 11, Issue:11 Topics: Adenosine Monophosphate; Clopidogrel; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Registries; Ticagrelor; Treatment Outcome	2022
Stearoyl-CoA Desaturase Regulates Angiogenesis and Energy Metabolism in Ischemic Cardiomyocytes. International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Chemokine CCL2; Chemokine CCL5; Energy Metabolism; Fatty Acids; Glucose; Hypoxia; Interleukin-1beta; Interleukin-6; Mice; Myocardial Infarction; Myocytes, Cardiac; Platelet-Derived Growth Factor; PPAR alpha; Protein Isoforms; Proto-Oncogene Proteins c-akt; Stearoyl-CoA Desaturase; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2022
Microtubule-Mediated Regulation of β Circulation research, 2023, Nov-10, Volume: 133, Issue:11 Topics: Adenosine Monophosphate; Animals; Cyclic AMP; Heart Failure; In Situ Hybridization, Fluorescence; Microtubules; Myocardial Infarction; Myocytes, Cardiac; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; RNA, Messenger	2023
Use of cangrelor during venoarterial extracorporeal membrane oxygenation following percutaneous coronary intervention. Artificial organs, 2020, Volume: 44, Issue:3 Topics: Adenosine Monophosphate; Aged; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies	2020
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction. Platelets, 2020, Nov-16, Volume: 31, Issue:8 Topics: Adenosine Monophosphate; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention	2020
Clinical use of cangrelor: a real-world multicenter experience from South Italy. Panminerva medica, 2022, Volume: 64, Issue:1 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Treatment Outcome	2022
Cyclic adenosine monophosphate regulates connective tissue growth factor expression in myocardial fibrosis after myocardial infarction. The Journal of international medical research, 2021, Volume: 49, Issue:6 Topics: Adenosine Monophosphate; Animals; Cardiomyopathies; Connective Tissue Growth Factor; Fibrosis; Mice; Myocardial Infarction; Transforming Growth Factor beta1	2021
Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury. Journal of the American Heart Association, 2018, 01-13, Volume: 7, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Hydrogen Peroxide; Immunity, Innate; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Rats, Sprague-Dawley; Recovery of Function; Stem Cell Niche; Tissue Scaffolds	2018
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention. Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:9 Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Tirofiban; Treatment Outcome	2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y Circulation. Cardiovascular interventions, 2019, Volume: 12, Issue:3 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome	2019
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? Platelets, 2020, Volume: 31, Issue:1 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Biomarkers; Disease Management; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Time-to-Treatment; Tomography, X-Ray Computed; Treatment Outcome	2020
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions, 2019, Volume: 12, Issue:7 Topics: Adenosine Monophosphate; Coronary Artery Disease; Coronary Thrombosis; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2019
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart (British Cardiac Society), 2013, Volume: 99, Issue:17 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Biomarkers; Creatine Kinase, MB Form; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Troponin	2013
Periprocedural type IVa myocardial infarction and the importance of platelet inhibition. Heart (British Cardiac Society), 2013, Volume: 99, Issue:17 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Creatine Kinase, MB Form; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Troponin	2013
Antiplatelet therapy. Cangrelor succeeds, at last, in PCI. Nature reviews. Cardiology, 2013, Volume: 10, Issue:6 Topics: Adenosine Monophosphate; Administration, Intravenous; Administration, Oral; Blood Platelets; Clopidogrel; Coronary Thrombosis; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome	2013
Study ignites debate on new anticoagulant. JAMA, 2013, May-01, Volume: 309, Issue:17 Topics: Adenosine Monophosphate; Drug Approval; Hemorrhage; Humans; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome	2013
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5 Topics: Adenosine; Adenosine Monophosphate; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Guanidines; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sulfones; Ticagrelor	2013
[The CHAMPION PHOENIX study]. Giornale italiano di cardiologia (2006), 2013, Volume: 14, Issue:10 Topics: Adenosine Monophosphate; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Double-Blind Method; Hemorrhage; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stents; Ticlopidine	2013
Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: the cangrelor efficacy challenge. Thrombosis and haemostasis, 2014, Volume: 111, Issue:1 Topics: Adenosine Monophosphate; Blood Platelets; Clopidogrel; Data Interpretation, Statistical; Humans; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Stents; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2014
Cangrelor for treatment during percutaneous coronary intervention. Future cardiology, 2014, Volume: 10, Issue:2 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Stents	2014
Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction. Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:9 Topics: Adenosine Monophosphate; Animals; Antigens, Ly; Cell Movement; Hyaluronan Receptors; Leukocyte Common Antigens; Leukotriene D4; Membrane Proteins; Mesenchymal Stem Cells; Mice, Inbred C57BL; Myocardial Infarction; Nerve Tissue Proteins; Purinergic P2Y Receptor Antagonists; Receptors, G-Protein-Coupled; Uridine Diphosphate Glucose	2014
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature, 2014, Nov-20, Volume: 515, Issue:7527 Topics: Adenosine Monophosphate; Animals; Aspartic Acid; Citric Acid Cycle; Disease Models, Animal; Electron Transport; Electron Transport Complex I; Fumarates; Ischemia; Malates; Male; Metabolomics; Mice; Mitochondria; Myocardial Infarction; Myocardium; Myocytes, Cardiac; NAD; Reactive Oxygen Species; Reperfusion Injury; Stroke; Succinate Dehydrogenase; Succinic Acid	2014
Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion. Basic research in cardiology, 2015, Volume: 110, Issue:2 Topics: Adenosine Monophosphate; Animals; Deoxyribonuclease I; Disease Models, Animal; Endodeoxyribonucleases; Hemodynamics; Male; Mitochondria; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins	2015
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation. Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:2 Topics: Adenosine Monophosphate; Animals; Blood Platelets; Cardiotonic Agents; Heart; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sphingosine	2016
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial. Journal of the American College of Cardiology, 2016, Feb-09, Volume: 67, Issue:5 Topics: Adenosine Monophosphate; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Research Design	2016
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction. Platelets, 2017, Volume: 28, Issue:4 Topics: Adenosine; Adenosine Monophosphate; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor	2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Aged; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clinical biochemistry, 2008, Volume: 41, Issue:14-15 Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Female; Humans; Hydrolysis; Male; Middle Aged; Myocardial Infarction; Ticlopidine	2008
Platelet inhibition with cangrelor. The New England journal of medicine, 2010, Mar-18, Volume: 362, Issue:11 Topics: Adenosine Monophosphate; Administration, Oral; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Infusions, Intravenous; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine	2010
Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts. Thrombosis and haemostasis, 2010, Volume: 104, Issue:1 Topics: Abciximab; Adenosine Monophosphate; Animals; Antibodies, Monoclonal; Blood Platelets; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardium; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reperfusion Injury; Ventricular Function, Left	2010
Testing a new approach for rapid and reversible platelet inhibition during percutaneous coronary intervention among patients with acute coronary syndrome. Hospital practice (1995), 2010, Volume: 38, Issue:1 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retreatment; Stents; Treatment Outcome	2010
Transplanted human cord blood-derived unrestricted somatic stem cells preserve high-energy reserves at the site of acute myocardial infarction. Cytotherapy, 2011, Volume: 13, Issue:8 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Energy Metabolism; Humans; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Paracrine Communication; Swine; Ventricular Function, Left	2011
Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts. Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:3 Topics: Adenosine Monophosphate; Animals; Cardiotonic Agents; Clopidogrel; Coronary Vessels; Female; Heart; In Vitro Techniques; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Platelet Activation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Purinergic P2Y Receptor Antagonists; Rabbits; Receptors, Purinergic P2Y12; Signal Transduction; Ticlopidine	2013
Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:2 Topics: Adenosine Monophosphate; Animals; Antibodies; Blood Pressure; Heart Rate; Macaca fascicularis; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Purinergic P2Y Receptor Antagonists	2013
Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:2 Topics: Adenosine Monophosphate; Animals; Antibodies; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Purinergic P2Y Receptor Antagonists	2013
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model. Arteriosclerosis, thrombosis, and vascular biology, 2003, Feb-01, Volume: 23, Issue:2 Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Animals; Bleeding Time; Blood Coagulation; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Disease Models, Animal; Dogs; Drug Combinations; Echocardiography; Female; Heparin; Infusions, Intravenous; Male; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Tissue Plasminogen Activator	2003
Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. Journal of cardiac failure, 1995, Volume: 1, Issue:5 Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Animals; Colforsin; Coronary Vessels; Heart Failure; Isoproterenol; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta	1995
Enhanced cardiovascular function and energy level by a novel chromium (III)-supplement. BioFactors (Oxford, England), 2006, Volume: 27, Issue:1-4 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apoptosis; Aspartate Aminotransferases; Blotting, Western; Body Weight; Chromium Compounds; Coronary Circulation; Dietary Supplements; Disease Models, Animal; Female; Heart Rate; Lipid Peroxidation; Male; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphocreatine; Phosphorylation; Protein Kinases; Rats; Rats, Sprague-Dawley	2006
CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation, 2007, Oct-16, Volume: 116, Issue:16 Topics: Adenosine; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Disease Models, Animal; Enzyme Induction; Ischemic Preconditioning, Myocardial; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium	2007
Protection of hypoxic myocardium by intracoronary administration of verapamil in open-chest dogs. Circulation, 1984, Volume: 70, Issue:4 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dogs; Energy Metabolism; Hemodynamics; Lactates; Lactic Acid; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption; Perfusion; Pyruvates; Pyruvic Acid; Verapamil	1984
Variations of 2,3-biphosphoglycerate (2,3-BPG) with oxygen therapy. Biochemical medicine, 1983, Volume: 30, Issue:2 Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Diphosphoglyceric Acids; Humans; Male; Myocardial Infarction; Oxygen Inhalation Therapy; Pneumonia	1983
Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis. Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:9 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Dogs; Hypoxanthines; Inosine; Myocardial Infarction; Myocardium; Necrosis; Purines	1980
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. The American journal of cardiology, 1981, Volume: 47, Issue:6 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Dogs; Lactates; Myocardial Infarction; Myocardium; Phosphocreatine	1981
Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart. Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:6 Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Enzyme Inhibitors; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rabbits	1997
Interstitial ATP level and degradation in control and postmyocardial infarcted rats. The American journal of physiology, 1998, Volume: 275, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Heart; Hypoxanthine; In Vitro Techniques; Inosine; Intracellular Fluid; Male; Microdialysis; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Time Factors; Xanthine	1998
Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ. The American journal of physiology, 1998, Volume: 275, Issue:4 Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Ischemic Preconditioning; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Rabbits; Theophylline	1998
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. European journal of pharmacology, 2000, May-03, Volume: 395, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate	2000
[Adenosine metabolism in the myocardium in experimental myocardial infarct]. Kardiologiia, 1979, Volume: 19, Issue:1 Topics: Adenosine; Adenosine Deaminase; Adenosine Monophosphate; AMP Deaminase; Animals; Dogs; Myocardial Infarction; Myocardium; Nucleotidases	1979
[Possible metabolic mechanisms of coronary circulatory disorder in an intact area of the left ventricle in experimental myocardial infarct]. Kardiologiia, 1979, Volume: 19, Issue:10 Topics: Adenosine; Adenosine Monophosphate; Aminohydrolases; Animals; Coronary Circulation; Coronary Disease; Dogs; Enzyme Activation; Heart Ventricles; Myocardial Infarction; Myocardium; Nucleotidases; Time Factors	1979
Protein and polynucleotide metabolism in skeletal muscles in dogs with experimental myocardial infarction. Cor et vasa, 1978, Volume: 20, Issue:4 Topics: Actomyosin; Adenosine Monophosphate; Alanine Transaminase; Amino Acids; Aminohydrolases; Ammonia; Animals; Aspartate Aminotransferases; Deoxyribonucleases; DNA; Dogs; Glutaminase; Hindlimb; Muscle Proteins; Muscles; Myocardial Infarction; Nucleotidases; Nucleotides; Ribonucleases; RNA; Urea	1978
Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism. International journal of clinical pharmacology and biopharmacy, 1975, Volume: 11, Issue:1 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Creatine; Dogs; Energy Metabolism; Fluoresceins; Lactates; Ligation; Mercury; Myocardial Infarction; Myocardium; Organomercury Compounds; Phosphocreatine; Phosphorus; Pyruvates; Water-Electrolyte Balance	1975
Effect on myocardial metabolic pattern of local complete and incomplete ischemia. Recent advances in studies on cardiac structure and metabolism, 1975, Volume: 7 Topics: Adenosine Monophosphate; Animals; Coronary Disease; Creatine; Disease Models, Animal; Dogs; Glycogen; Heart Ventricles; Lactates; Myocardial Infarction; Myocardium; Phosphocreatine; Time Factors	1975
Global depletion of myocardial norepinephrine and ATP after left coronary artery occlusion in rats. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1992, Volume: 13, Issue:4 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Epinephrine; Female; Male; Myocardial Infarction; Myocardium; Norepinephrine; Propranolol; Rats; Rats, Wistar; Verapamil	1992
Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. The American journal of physiology, 1986, Volume: 251, Issue:6 Pt 2 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Pressure; Coronary Disease; Dogs; Energy Metabolism; Female; Kinetics; Male; Myocardial Infarction; Myocardium; Necrosis	1986
Demonstration of serum creatine kinase isoenzymes by fluorescence technique. Clinica chimica acta; international journal of clinical chemistry, 1972, Volume: 40, Issue:1 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Blood Protein Electrophoresis; Creatine Kinase; Fluorescence; Humans; Isoenzymes; Methods; Muscular Dystrophies; Myocardial Infarction; Phosphotransferases; Staining and Labeling; Tetrazolium Salts	1972
Metabolic control of rat heart glycolysis after acute ischaemia. Fluoracetate treatment and thyroid interactions. Journal of molecular and cellular cardiology, 1971, Volume: 2, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Fluoroacetates; Fructosephosphates; Glucosephosphate Dehydrogenase; Glucosephosphates; Glyceraldehyde; Glycerolphosphate Dehydrogenase; Glycerophosphates; Glycolysis; Hexokinase; Hypothyroidism; Hypoxia; Ischemia; Male; Myocardial Infarction; Myocardium; Phosphates; Phosphofructokinase-1; Phosphogluconate Dehydrogenase; Pyruvate Kinase; Pyruvates; Rats; Thyroid Gland; Thyroid Hormones	1971
[Energy metabolism of right ventricular myocardium following section of the left coronary artery]. Kardiologiia, 1973, Volume: 13, Issue:3 Topics: Acute Disease; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Vessels; Dogs; Glycogen; Glycolysis; Heart Ventricles; Mitochondria, Muscle; Myocardial Infarction; Myocardium; Oxidative Phosphorylation; Oxygen Consumption; Phosphocreatine	1973
[Effect of intra-aortic balloon counterpulsation on the hemodynamics and the metabolism of the non-ischemic and ischemic left heart ventricle]. Zeitschrift fur experimentelle Chirurgie, 1973, Volume: 6, Issue:5 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Assisted Circulation; Blood Pressure; Disease Models, Animal; Dogs; Heart; Heart Ventricles; Hemodynamics; Lactates; Ligation; Myocardial Infarction; Myocardium; Shock, Cardiogenic	1973
Increased coronary venous inorganic phosphate concentrations during experimental myocardial ischemia. The American journal of cardiology, 1972, Volume: 30, Issue:5 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Coronary Vessels; Dogs; Lactates; Ligation; Myocardial Infarction; Myocardium; Phosphates; Potassium; Rats; Time Factors; Veins	1972
Stimulation of DNA synthesis and AMP deaminase activity in rat hearts during isoproterenol-induced myocardial infarction. Chemico-biological interactions, 1970, Volume: 2, Issue:3 Topics: Adenosine Monophosphate; Aminohydrolases; Animals; DNA; DNA Repair; Female; Heart Atria; Heart Ventricles; Isoproterenol; Kinetics; Lithium; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains	1970